Bionano Genomics, Inc. (LON:0A4K)

Market Cap	9.28M
Revenue (ttm)	24.58M
Net Income (ttm)	-89.48M
Shares Out	n/a
EPS (ttm)	-70.40
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,768
Average Volume	9,566
Open	5.70
Previous Close	5.58
Day's Range	5.19 - 5.88
52-Week Range	0.16 - 1.51
Beta	n/a
RSI	28.30
Earnings Date	May 14, 2025

About Bionano Genomics

Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. The company offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA lin...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2003
• Employees: 100
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A4K

Financial Performance

In 2024, Bionano Genomics's revenue was $30.78 million, a decrease of -14.79% compared to the previous year's $36.12 million. Losses were -$112.02 million, -51.82% less than in 2023.

Financial numbers in USD